Addressing the Challenge of NCDs in LAC: Brazil Country Case Study Isabella Danel Christoph Kurowski.

Slides:



Advertisements
Similar presentations
noncommunicable diseases
Advertisements

Health Statistics and Informatics Global Burden of Disease 2004 Update: Selected figures and tables Health Statistics and Informatics Department.
GARD Global Alliance against Chronic Respiratory Diseases WHO J Bousquet, R Dahl, N Khaltaev, HJ Bekedam.
Diabetes: Public Health Implications Dr. Bruce Goodrow East Tennessee State University.
Economic Impact of a Sedentary Lifestyle. Exercise and Body Composition The health care costs associated with obesity treatment were estimated at $117.
NON COMMUNICABLE DISEASES UNIT Presented by : Mr. Omar Mwalimu.
Mississippi Task Force on Heart Disease and Stroke Prevention 2008 Current Status J. Clay Hays, Jr, MD, FACC.
Summary Measures of Population Health: Measuring the impact of disease, injuries and risk factors.
 Currently 150 Million people worldwide suffering from diabetes and that number may double by the year  The prevalence of type 2 diabetes is dramatically.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 4.
Non Communicable Disease
Dr Ala Alwan Assistant Director-General Noncommunicable Diseases and Mental Health World Health Organization Scope, Objectives and Agenda.
Chapter Twelve Importance of Noncommunicable Disease.
 Cerebrovascular disease and heart disease are the second, third of the leading causes of death.  Years of life lost are much more than other disease.
Coronary Heart Disease (CHD): A Disease of Affluence.
Public Health and Prevention M6920 September 18, 2001.
Course 17: Neglected Tropical Diseases & NCDs 9 th GA of IAPB Hyderabad; 19 th September 2012 NCDs & Eye Health Converging interests and opportunities.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Healthy Ireland A framework for improved health and wellbeing Healthy Food for All 20 November 2013 Dr Miriam Owens.
International Health NUR 410 Community Focused Nursing Catherine T. Horat.
The Oxford Health Alliance The Oxford Health Alliance Community Interventions for Health (CIH) Sponsored by the PepsiCo Foundation.
Non-communicable diseases David Redfern
St. Clair Health Care Commission Mobilizing for Action through Planning & Partnership Community Health Status Assessment.
Combating disease and improving health Presented by ROSANNA AGBLE at Taking Action for the World’s Poor and Hungry People Beijing, China October 17–19,
The National Health Priority Areas
Health Status of Australian Adults. The health status of Australians is recognised as good and is continually improving. The life expectancy for males.
T.D. Medical College,Alappuzha
The Role of the World Bank in The Role of the World Bank in Addressing Childhood Obesity Dr. Shiyan Chao The World Bank PACO III HIGH LEVEL MEETING ON.
Terms: Epidemiologic Transition Gaziano 2005 Stage 1Malnutrition and infectious diseases are the leading causes of mortality and morbidity Stage 2Improved.
Present NCDI situation in Mongolia
The wider determinants of health: Theory into practice Inequalities in Health: trends, causes and policy Joop ten Dam PhD NIGZ Support centre for Community.
NHPA’s. What are they? National Health Priority Areas (NHPAs) are diseases and conditions chosen for focused attention at a national level because of.
International Health Policy Program -Thailand Phusit Prakongsai, MD. Ph.D. Walaiporn Patcharanarumol, MSc. Ph.D. Viroj Tangcharoensathien, MD. Ph.D. International.
4 th SIDS Meeting, Sao Tome & Principe April |1 | NCDs in the context of the revised Health Promotion Strategy.
Healthy Living and Diabetes workshop. Content of the workshop Introduction to chronic non-communicable diseases and IPSF activities in the past on that.
Group 7 Burden of disease in Brazil. KEY HEALTH INDICATORS Years of life lost (YLLs): Years of life lost due to premature mortality. Years lived with.
The Chronic Disease problem in the Caribbean – civil society perspective Twelfth OECS Health Ministers Meeting, 11 th September 2009 Prof. Trevor A. Hassell.
Joseph Perriëns MD, PhD Dept of HIV/AIDS World Health Organization
WORLD HEALTH ORGANIZATION Source: World Health Report 2000 JS 3/01 WHO Statistics, 2000 Dr. Rüdiger Krech A/Regional Adviser, Healthy Ageing World Health.
HEALTHY KANSANS 2010 PROCESS OVERVIEW Encourage Change Improve the Health of all Kansans February 16 th, 2007.
Evidence-based priority setting for the National Health Development Plan of Thailand Walaiporn Patcharanarumol, Kanitta Bundhamcharoen, Phusit Prakongsai,
Health risk distribution by socio-economic status and educational levels of Thai households: Who smokes and drinks more? BACKGROUND: Tobacco and alcohol.
Meeting the Challenge of Non-Communicable Diseases Lecture 14.
The Disease Control Priorities Project ( and Chronic Disease Presentation to the Hemispheric Meeting of the Social Protection.
Call to action on NCDs: Challenges and Way Forward for Maternal and Child Health Dr. Niloufer Sultan Ali Professor, Family Medicine Aga Khan University,
The Burden of Chronic Diseases in the Developing World Stephen J. Spann, M.D., M.B.A. Professor and Chairman Department of Family and Community Medicine.
Comparing Australia with Developing Countries Morbidity, life expectancy, infant mortality, adult literacy and immunisation rates can be used to compare.
PowerPoint Presentati on TOPIC: Tobacco: A leading risk factor for Non-Communicable Diseases.
Public Health Agency of Canada Agence de la santé publique du Canada Macroeconomic Impacts of Prevention Policies for NCDs 1 Making the Case to the Finance.
Chronic Disease A Public Health Perspective. Chronic Disease Overview The most prevalent, costly, and preventable chronic diseases –cardiovascular disease.
Chapter 7: Epidemiology of Chronic Diseases. “The Change You Like to See….” (1 of 3) Chronic diseases result from prolongation of acute illness. – With.
An Overview of the Burden of Non- Communicable Diseases (NCDs) Dr Sylvia J Anie Director Social Transformation Programmes Division (Education, Health,
Economic and Social Aspects of NCDs SDE Seminar Series/PAHO 25 April, 2012 Rachel Nugent.
Cardiovascular Risk: A global perspective
Nick Banatvala & Pascal Bovet
Dr Prak Piseth Raingsey Director Department of Preventive Medicine
Chronic Non-Communicable Diseases
NCD policy and programming in Croatia
Chronic NCDs in Sri Lanka : Policy to Public Health approaches
بسم الله الرحمن الرحيم.
DR GHULAM NABI KAZI WHO Country Office Pakistan
NCD in Bulgaria Assoc. Prof. Plamen Dimitrov, MD, PhD
Non-Communicable Diseases Risk Factors Survey in Georgia
Prevention and Control of Noncommunicable Diseases
How does teamwork improve value. Dr Nils E
prevention and control of non communicable diseases in Iraq
GARD/NCD Action Plan & 2011 UN Summit on NCDs
Welcome and Introductions: Tell Us About Yourself
European Strategy for the Prevention and Control of Noncommunicable Diseases & Strategies for Promotion of Healthy Lifestyles St Petersburg. Russian Federation.
NCD – Kingdom of Saudi Arabia
Presentation transcript:

Addressing the Challenge of NCDs in LAC: Brazil Country Case Study Isabella Danel Christoph Kurowski

Brazil Country Case Study  To inform policy dialogue  Lessons learned from developed countries and the potential applicability of the most CE strategies in Brazil  Potential impact of expanding health promotion and improved NCD management on health outcomes  Costs and returns from expanding health promotion and improved NCD management activities  To inform current and future health project (VIGISUS 2 and 3, FHP)  To develop and pilot a model for assessing NCD prevention and control issues in other countries Objectives:

Brazil Overview  Largest country in LAC  Population 186 million; 80% urban  Large health disparities  Universal health system since 1990  Decentralized  Family Health Program  % of GDP spent on health: 7.6  Basic health indicators: LE: 69 / aging population TFR: 2.2 IMR: 30 (48 in 1990) HALE at birth: 57/62 (male/female )

Burden of Disease by Major Disease Groups, Brazil 1998 Source: BOD study 2002 Thousands of Disability-Adjusted Life Years 24% 21% 55%

Burden of Disease, Brazil 1998 Source: BOD study 2002 Thousands of Disability-Adjusted Life Years, Divided into YLLs and YLDs

Comparison of Years of Life Lost Among Several Diseases Thousands Years of Life Lost due to Premature Mortality Source: BOD study 2002

Avoidable DALYs: Brazil compared to Amer-A* BrazilAmeri-A CausesRate / 1000 ALL Communicable Maternal Perinatal, Nutritional Infectious, parasitic Respiratory infection Maternal Perinatal Nutritional <1 2 1 Non-communicable Cancer Diabetes Neuro-psychiatric Cardiovascular Chronic respiratory Other Injuries Unintentional Intentional * Very low child and adult mortality: Canada Cuba, USA

Prevalence of risk factors in Brazil  Study on nutrition / obesity data is national; all others are smaller studies  Behavioral Risk Factor Survey in most capital cities has been completed – data not yet available  Multiple studies showing wide ranges:  Tobacco – 35-50% for men; 20-33% for women  Inactivity – 45-60% in men; 60-80% in women  Obesity – 10% in adults in ’89 (national survey)  Hypertension – 20-30% in adults; higher among lower SES  Tendencies  Obesity increasing: 6% among adults in ’75; 10% in ’89; also increasing among the poor: 3.6% for lowest female tercile in ’75, 9.7% in ’89  Diabetes increasing: 7.6 / 100,000 for < 15 years old in ’93 (SP); 12.7 in ’98

The challenge of NCD’s in Brazil Preliminary results of an economic evaluation

Objectives For a subset of largely preventable NCDs, to  estimate the financial costs of treatment and care;  estimate the future burden of disease;  estimate the future financial and economic costs; and  estimate the financial costs of health promotion in comparison with the financial and economic benefits.

Model (I) Diabetes mellitus Ischaemic heart disease Ischaemic stroke Chronic obstructive pulmonary disease Cancer (trachea, bronchi, lungs) Physical inactivity Arterial hypertension Smoking

Current costs of treating a subset of NCD’s [2002/03] Risk factorSec. DiseaseUSD 2000 [billion] Physical inactivityIHD, CVD*, DM3.4 Arterial hypertension IHD, CVD3.2 Smoking IHD, COPD, “lung” cancer 3.5 Total10.2

Future burden of disease 2005/ LE

Future burden of disease – selected conditions by risk factor: 2005 to 2010 Risk factorSec. DiseaseBoD [DALY, million] Physical inactivityIHD, CVD*, DM4.9 Arterial hypertension IHD, CVD12.6 Smoking IHD, COPD, “lung” cancer 3.7 Total21.2

Future costs due to NCD’s 2005/2010 Future costs (status quo persists):  Financial costs: Costs of treating secondary diseases  Economic costs: Financial costs plus productivity losses due to disability and premature mortality

Future economic costs due to NCD’s: 2005/2010 Risk factorSec. DiseaseEconomic costs [ USD, 2002, billion] Physical inactivityIHD, CVD*, DM$130.0 Arterial hypertension IHD, CVD$215.2 Smoking IHD, COPD, “lung” cancer $122.0 Total$467.2

Model II Physical inactivity Arterial hypertension Smoking Scaling up of AGITA SAO PAULO Treatment of 25% of population c hypertension 10% increase in prices of cigarettes Medical counseling for 25% of smokers

Scaling up of AGITA SAO PAULO Intervention: Expansion of program to 25% of population Financial costs of providing intervention 131 million DALY’s averted127,000 Financial costs in care of secondary diseases averted 572 million Losses in productivity averted452 million Benefit cost ratio7.8 Costs in USD 2000

Benefit cost ratios Scaling up of AGITA SAO PAULO Treatment of 25% of population c hypertension 10% increase in prices of cigarettes Medical counseling for 25% of smokers

Conclusions  NCDs consume a large share of Total Expenditure on Health  Future economic costs accruing over the period of 2005/2010 equal approximately 70% of GDP in 2002  Effective interventions to prevent NCD’s exist. Some are financially and economically highly attractive.

Ministry of Health Response to Health Transition  Fragmented national policies:  National policy to reduce injuries and violence  National anti-tobacco and anti-drug policy  National Food Security policy  National and State Cancer Control policies  National and State Occupational Health policies  Policies not yet operationalized in national / state / municipal health plans  Health Muncipalities project, 2002, UNSP

Ministry of Health Structure  Executive Secretariat responsible for establishing health promotion policies and coordinating cross- cutting program  Fragmented national structure:  No one unit responsible for health promotion activities  Four secretariats involved  Greater activity in some states e.g. Sao Paulo

Ministry of Health:primary health care  Eight Family Health Program priorities include:  Control of hypertension and diabetes  Health promotion  National plan and guidelines available for hypertension and diabetes detection and control, but not health promotion  Plan has been implemented through training, IEC campaigns, community work  Performance measures on hospitalization and mortality; none for risk factors or HP activities  In process of defining policies to promote healthy lifestyles, health promotion and risk prevention.

Interventions in tobacco  National Tobacco Control Program established, 1987  Advisory Board on Tobacco Use Control established, 1987  Warning on cigarettes, 1988; bolder in 2001  Restricted tobacco advertising, 1994  Smoking banned in MOH, 1998  Tobacco considered drug and regulated by ANVISA, 1999  Various media campaigns  Tobacco advertising only at point of sale, 2000  Tobacco use education and control programs in the workplace, schools, and health units

Next steps  National health promotion plan -- involvement of multiple sectors; address issues at various levels  Clearly defined priorities and targets  Commitment to financing  Structure that facilitates action  Scale up cost-effective interventions shown to work in Brazil  Piloting interventions found to be cost-effective in other countries based on priorities  HP performance measures include in pactos  Information systems to monitor impact and trends